Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.39 |
| ▸ | TLR2 | O60603 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CASP2 | P42575 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13699538 | 0.84 | APLNR (0.34) | GLP1RTLR2MEN1KMT2AMAPT | |
| SCHEMBL13699519 | 0.82 | GLP1R (0.37) | GLP1RTLR2MEN1KMT2AFAAH | |
| SCHEMBL13936546 | 0.80 | MEN1 (0.59) | MEN1KMT2ACASP2MAPTFAAH | |
| SCHEMBL14089798 | 0.77 | MEN1 (0.50) | GLP1RMEN1KMT2AFAAH | |
| SCHEMBL13445937 | 0.76 | TSHR (0.38) | TLR2MEN1KMT2AFAAH | |
| SCHEMBL17177988 | 0.74 | MEN1 (0.68) | MEN1KMT2ACASP2FAAH | |
| SCHEMBL12154988 | 0.73 | MEN1 (0.45) | MEN1KMT2AFAAH | |
| SCHEMBL13498572 | 0.73 | MEN1 (0.48) | MEN1KMT2A | |
| SCHEMBL16072748 | 0.72 | TSHR (0.50) | MEN1KMT2ACASP2MAPTFAAH | |
| SCHEMBL13936565 | 0.72 | GLP1R (0.34) | GLP1RTLR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090240028-A1 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides | NOVO NORDISK A/S (DK) | 2009-09-24 | — | — | US | disclosed |
| US-20090240028-A1 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides | NOVO NORDISK A/S (DK) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240028-A1 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides | VIP, PTMS, PDGFA | GLP1R 103/4885TLR2 3322/4885MEN1 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.